Natera Inc
General ticker "NTRA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $20.7B
Natera Inc follows the US Stock Market performance with the rate: 69.8%.
Estimated limits based on current volatility of 3.0%: low 154.46$, high 164.14$
Factors to consider:
- US accounted for 96.8% of revenue in the fiscal year ended 2023-12-31
- Current price 102.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [41.09$, 79.86$]
- 2024-12-30 to 2025-12-30 estimated range: [39.46$, 77.26$]
Financial Metrics affecting the NTRA estimates:
- Negative: Non-GAAP EPS, $ of -3.79 <= 0.10
- Negative: Operating profit margin, % of -29.19 <= 1.03
- Negative: Operating cash flow per share per price, % of -3.55 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term NTRA quotes
Long-term NTRA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $625.49MM | $820.22MM | $1,082.57MM |
| Operating Expenses | $1,093.66MM | $1,361.26MM | $1,528.82MM |
| Operating Income | $-468.17MM | $-541.04MM | $-446.25MM |
| Non-Operating Income | $-2.92MM | $-5.78MM | $11.71MM |
| Interest Expense | $8.30MM | $9.32MM | $12.64MM |
| R&D Expense | $264.21MM | $316.42MM | $320.68MM |
| Income(Loss) | $-471.10MM | $-546.82MM | $-434.53MM |
| Taxes | $0.62MM | $0.98MM | $0.27MM |
| Profit(Loss) | $-471.72MM | $-547.80MM | $-434.80MM |
| Stockholders Equity | $653.30MM | $705.74MM | $765.33MM |
| Inventory | $26.91MM | $35.41MM | $40.76MM |
| Assets | $1,236.49MM | $1,394.47MM | $1,441.70MM |
| Operating Cash Flow | $-335.24MM | $-431.50MM | $-246.96MM |
| Capital expenditure | $41.03MM | $47.70MM | $39.20MM |
| Investing Cash Flow | $-205.19MM | $330.34MM | $168.50MM |
| Financing Cash Flow | $576.19MM | $482.64MM | $254.46MM |
| Earnings Per Share* | $-5.21 | $-5.57 | $-3.78 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.